1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Sorafenib: new trials by email Literature Review of Sorafenib trials Research Report on Sorafenib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC TACE combined with sorafenib and PD-1 mAb - Hepatocellular Carcinoma, Liver Neoplasms | Phase 2 | Completed | Sichuan Cancer Hospital and Research Institute | 27 | 2020-09-14 | 2024-06-25 |
Carcinoma, Hepatocellular (1) · Digestive System Neoplasms (1) · Liver Diseases (1) · Liver Neoplasms (1)
Adenocarcinoma (1) · Carcinoma (1) · Digestive System Diseases (1) · Neoplasms (1) · Neoplasms by Histologic Type (1) · Neoplasms by Site (1) · Neoplasms, Glandular and Epithelial (1)
Sorafenib (1)
Sichuan Cancer Hospital and Research Institute (1)
China (1)